



Impact of waiting time for first clinic assessment and seizure outcomes of pediatric epilepsy 
Submitted to the College of Graduate and Postdoctoral Studies 
in Partial Fulfillment of the Requirements for the Degree of 
Master of Science 
 in the Department of Community Health and Epidemiology 









 Copyright Asma Khan, May, 2019. All rights reserved. 
 
i 
PERMISSION TO USE 
In presenting this thesis in partial fulfillment of the requirements for a postgraduate degree 
from the University of Saskatchewan, I agree that the Libraries of this University make it freely 
available for inspection. I further agree that permission for copying of this thesis in any manner, 
in whole or in part, for scholarly purposes may be granted by the professor who supervised my 
thesis work or, in his absence, by the Head of the Department or the Dean of the College in 
which my thesis was done. It is understood that any copying or publication or use of this thesis 
or parts thereof for financial gain shall not be allowed without my written permission. It is also 
understood that due recognition shall be given to me and to the University of Saskatchewan in 
any scholarly use which may be made of any materials in my thesis.  
Requests for permission to copy or to make other use of material in this thesis in whole or part 
should be addressed to: 
Head of the Department of Community Health and Epidemiology 
University of Saskatchewan 
107 Wiggins Road 




Dean College of Graduate and Postdoctoral Studies 
University of Saskatchewan 
116 Thorvaldson Building, 110 Science Place 
Saskatoon, Saskatchewan Canada  
S7N 5C9  
ii 
ABSTRACT 
Introduction: Pediatric epilepsy has increased in global incidence. Children with epilepsy 
require immediate healthcare evaluation and monitoring. Waiting times between first seizure 
onset and pediatric neurology assessment may impact seizure outcome at follow-up. Quality of 
medical care for children with first seizure onset will be assessed and the impact of pediatric 
neurology clinic waiting times on seizure outcomes will be determined.  
Methods: This retrospective study, based on chart review, includes patients with first seizure 
evaluation at the Royal University Hospital in Saskatoon between January 2012 and December 
2015. The interim period before first assessment and other factors were studied in relation to 
seizure outcome on follow-up. 
Results: 1158 patients were assessed. 197 patients had epileptic events. The mean age of 
patient at diagnosis was 6.2 years (±5.2). The mean waiting time for assessment by a pediatric 
neurologist was 4.3 (±3.6) months. The mean duration of follow-up was 20.9 (±11.0) months. At 
the last seizure assessment, 132 patients were seizure-free and 65 patients had seizure 
recurrence. Factors independently associated with poor seizure outcome included waiting time, 
language not age-appropriate, and gait not age-appropriate. Factors collectively associated with 
poor seizure outcome included waiting time and gait not age-appropriate. Total number of anti-
epileptic drugs was significant at 18 months in both univariate and multivariate models. 
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Conclusion: First seizure assessment is crucial for management of children with epilepsy. 
Waiting time and other factors may influence seizure outcome, representing opportunities to 
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CHAPTER 1: INTRODUCTION 
1.1 Overview 
Epilepsy is a severe condition that encompasses a multitude of serious symptoms and requires 
unique medical treatment from a specialist. This disease is most common amongst children and 
therefore requires the attention of a pediatric neurologist (Engel et al., 2005). In order to 
receive service, there is a period of waiting time between the first seizure experienced and the 
first visit to a pediatric seizure clinic for diagnosis and treatment. This period of waiting time 
can have an immense impact on the development of a child and further necessitates the 
urgency for treatment (Appleton et al., 1998; Berg et al., 2014; Clare et al., 1978). This study will 
explore the impact of not receiving urgent medical attention for a first suspected seizure and 
determine how this affects the seizure outcome of children with an onset of epilepsy, whether 
that involves transitioning to a seizure-free state or continuing to have further seizure 
treatment provided by a physician.   
1.2 Rationale 
Epilepsy is one of the most common serious neurological disorder in existence (WHO, 2019). 
This is a problem in Saskatchewan where there is only one pediatric seizure clinic. Saskatoon 
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and its surrounding area is within a centralized location, however, the rest of the province often 
has to rely on their own resources for further medical assistance before being seen by a 
specialist in Saskatoon. This presents an issue when travelling from rural and remote areas of 
the province where transportation services are not as convenient or readily attainable. 
Accurately understanding the impact of waiting times on child development is crucial because 
of the critical period of growth that childhood calls for. A clear understanding of the factors 
associated with waiting time in a pediatric epilepsy clinic could help in deciding which 
interventions will have the greatest impact in improving the clinical course of epilepsy and 
resiliency.  
The results of this study can prospectively improve the quality of patient care by indicating the 
developmental impact of a child who experiences a seizure and requires medical attention. This 
notion is not currently well understood enough to benefit from and it could make a difference 
towards how pediatric neurologists prioritize their visits and time, reducing waiting times for 
first seizure clinical evaluations.    
By understanding and informing the Saskatoon Health Region (SHR) of its waiting times in 
pediatric epilepsy services, Saskatchewan populations outside of the SHR should have better 
access to these services. This study will also advise the Health Sector of the Government of 
Saskatchewan and the SHR under investigation on best practices and provide evidence for 
sustaining optimal epilepsy and pediatric epilepsy health services in the province. This will 




1.3 Purpose of the study 
The purpose of the study is twofold: 
1.3.1 Primary purpose 
A first seizure clinic appointment is crucial for a child because of the critical period of brain 
maturation and growth involved; therefore, the main purpose of this study is to understand the 
effects of pediatric seizure clinic waiting times between a first suspected seizure and a first 
clinic appointment. This will be achieved by recognizing epileptic children with the highest risk 
of a poor seizure outcome based on a number of independent seizure variables including: sex, 
age, residential location, seizure type, frequency, and treatment.   
1.3.2 Secondary purpose 
The results of this study will lead to improving the quality of patient care by identifying seizure 
management and the developmental impact of a child with a diagnostic delay. This notion is 
not currently understood to its full benefit and it has the potential to change how physicians 
prioritize their time, shortening the waiting time of first clinical evaluations. Additionally, health 
service authorities may need to extend the medical care resources and this study would identify 
that.   
1.4 Research objectives 
There are four objectives in this study: 
Objective 1. To identify whether the waiting time experienced between seizure onset and   
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                      first clinic appointment for diagnosis by a pediatric neurologist has an impact   
                      on a child’s seizure outcome; 
Objective 2. To identify whether language development is associated to seizure outcome; 
Objective 3. To identify whether motor development is associated to seizure outcome; and 
Objective 4. To identify whether residential location are associated to seizure outcome 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Overview 
This section includes a brief introduction of pediatric epilepsy. The epidemiology of pediatric 
epilepsy at a global, national and local level is also discussed. Measures of the illness and 
precipitating factors will also be depicted.  
2.2 Background of pediatric epilepsy 
Epilepsy is a unique and complex condition involving a large variety of symptoms and 
presentations. This can be problematic for parents, guardians, and close social networks as well 
as professionals working in the health sector since the care of each epileptic child varies. 
Epileptic children are disadvantaged by various developing skills such as language, motor, and 
cognitive functions when compared to the general childhood population (Desai, 2008). 
Cognitive impairments observed in epileptic children include deficits in attention, memory, 
academic success, and lower mean IQ scores (MacAllister & Schaffer, 2007). These children also 
demonstrate problems with social development and stigma because of these impairments 
(Austin et al., 2004).   
Pediatric epilepsy is a neurological condition involving the rapid and unexpected altercation in 
how brain cells transmit electrical signals causing children to have seizures (Al-Biltagi, 2014).  
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Epilepsy can be a chronic condition or it can involve recurring seizures. A seizure presents itself 
when there is an abrupt discharge or disturbance of the electrochemical firing of neurons that 
cause altercation to an individual’s sensation, perception, or behaviour (DuLac, MacDonald, & 
Kelly, 1995). Numerous factors contribute to the medical and psychosocial difficulties faced by 
epileptic children. Investigating potential methods of minimizing this impact, such as 
maximizing the child’s involvement in normal childhood activities, can benefit the wellbeing of 
children and in turn, their families (England et al., 2012). Currently, there are gaps in the 
research regarding the relationship between various seizure-related variables and 
developmental impact.  With awareness to this gap, the next step for researchers is to 
determine the impact of seizure-related variables on the impact of children who are diagnosed 
with epilepsy. 
2.3 Epidemiology of pediatric epilepsy 
2.3.1 Global 
Over 50 million individuals worldwide have active epilepsy (WHO, 2019). About 20% (10.5 
million) are children under 15 years old (Guerrini, 2006).  There are 3.5 million individuals 
diagnosed with epilepsy each year and 40% of them are under 15 years old. More strikingly, 
only 20% of these children live in developed countries (Guerrini, 2006). Population-based 
studies on pediatric epilepsy indicate annual incidence rates of 61-124 per 100,000 in 
developing countries while the annual incidence is 41-50 per 100,000 in developed countries 
(Guerrini, 2006). Incidence gradually decreases from an estimate of 150 per 100,000 in the first 
year of life to 45-50 per 100,000 after a child reaches the age of 9 years old (Guerrini, 2006). 
Cumulative incidence studies provide evidence that up to the age of 15 years old, 1.0-1.7% of 
children will have a minimum of one unprovoked seizure, and 0.7-0.8% will experience 
repeated seizures (Guerrini, 2006). Frequency rates in North America and Europe vary between 
3.6-6.5 per 1000 in contrast to African and Latin American studies that report rates of 6.6-17 
per 1000 (Guerrini, 2006). 
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In the USA, a substantial proportion of those with uncontrolled (refractory) epilepsy are 
uninsured, have a lower socioeconomic status (SES), and reside in rural dwellings (Kenney & 
Mann, 2013).  About 20% of the country’s citizens live rurally but only 9% of its physicians 
practice in these areas.  It is the characteristics of this vulnerable population such as this that 
deter the ability to self-manage ongoing care needs and comply with prescribed therapies, 
leading to greater usage of critical health care resources, such as emergency departments 
(Kenney & Mann, 2013).  
About 80% of those with epilepsy are living in low- and middle-income countries and 75% of 
them may not receive appropriate treatment (WHO, 2019). This includes children in Nigeria, 
China, Pakistan, and Panama (WHO, 2010). 
2.3.2 Canada 
Epilepsy Canada considers epilepsy to be a neurological disorder affecting an average of 15,500 
individuals every year (Epilepsy Canada, 2016) and the incidence of pediatric epilepsy in Canada 
is 41 per 100,000 children per year (Camfield, 1996). Of this number, 44% are diagnosed before 
the age of 5, 55% are diagnosed before the age of 10, and 75-85% of those with epilepsy are 
diagnosed before age 18. Prior to turning 14 years old, 1% of diagnosed children have recurrent 
seizures (Epilepsy Canada, 2016). In approximately half of epileptic children, seizures disappear 
completely, a statistic which illustrates the vast number of children who bring symptoms into 
adulthood.  
Estimates of the prevalence of pediatric epilepsy largely depend on how epilepsy is 
defined. Two cycles of data were analyzed based on cycles conducted from the National 
Longitudinal Survey of Children and Youth (NLSCY) between 1996-1997 and 1998-1999 (Prasad, 
2011). Families were asked if their child had epilepsy that had been diagnosed by a health care 
professional. The prevalence for children between 0-13 years was 4.03 per 1, 000 and it was 
5.26 in the age groups 0-15 years old (Prasad, 2011).   
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Age-specific incidences of pediatric epilepsy were 118 for every 100,000 children younger than 
1 year, 48 per 100,000 from 1 to 5 years, 43 per 100,000 from 6 to 10 years, and 21 per 100,000 
from 11 to 15 years (Camfield et al., 1996). 
The incidence and prevalence rates of pediatric epilepsy illustrate that the illness is a 
considerably common condition that not only can impact numerous children and households 
across Canada but can also occur multiple times in the same child.  
A Canadian study conducted in Manitoba (Kozyrskyi & Prasad, 2004) observed the province’s 
rural south, the north, Winnipeg, and Brandon. The study focused on the impact of access in 
residing in a rural environment versus an urban environment towards pediatric health care 
services and if socioeconomic status (SES) has an impact on access.   
Age-specific prevalence rates for pediatric epilepsy in Manitoba were determined by health 
care administrative records. Higher prevalence rates were discovered in children of all ages 
living in lower SES neighbourhoods in urban areas, which showed a gradient of higher 
prevalence amongst lower levels of income (Kozyrskyi & Prasad, 2004).  
Population-based health care administrative data was used to describe the geographical 
distribution of pediatric epilepsy. The data collected in the study by Kozyrskyi and Prasad (2004) 
suggested that the burden of seizure disorders is not evenly distributed among children.  The 
association with income was strongest in the youngest and oldest children.  In rural areas, 
children 5 years and younger and with lower levels of SES had a greater prevalence of seizure 
disorders (Kozyrskyi & Prasad, 2004). 
2.3.3 Saskatchewan 
There are only self-reported prevalence rates of epilepsy in Saskatchewan. The Community 
Health Survey (CHS) indicates the prevalence is 5.0 per 1000 whereas the National Population 
Health Survey (NPHS) indicates a prevalence of 5.2 per 1000. These are not age-specific rates 
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but CHS only surveys individuals 12 years and older whereas the NPHS includes individuals from 
all age groups (Tellez-Zenteno, 2004). 
2.4 Waiting time outcome in pediatric epilepsy 
First clinic visits are an important consideration in confirming seizure diagnosis, addressing 
appropriate management of the illness, and counseling parents about their stressful concerns 
regarding the newly diagnosed illness (England et al., 2012). Waiting for the first appointment 
can be a strenuous experience for the parent and the child who may have a potential of 
epilepsy. 
Jallon et al (2001) observed first unprovoked seizures and those with previously undiagnosed 
epilepsies at initial presentation in a large cohort of 1942 patients comprised of both children 
and adults. In this study, the time between first seizure and epilepsy diagnosis ranged from 1 
day to 52 years, with an average of 7 months. Seizures were undiagnosed due to a lack of 
access to medical care, unawareness of the illness, and patients believed they previously had 
medical attention but the events were not diagnosed as seizures. 
Berg et al (2014), a researcher in the effects of waiting times on pediatric epilepsy, observed 
how diagnostic delays (hereinafter termed as waiting times) impact the development of 
children and factors that affect waiting times. Their study supported the hypothesis that 
waiting times correspond to less ideal developmental outcomes. Results were considerably 
poorer in those delayed over a month. A number of variables were incorporated: seizure type, 
presentation, parental education, and the epileptic child’s ability to tolerate drugs. The effect of 
waiting times was significant with greater waiting times leading to poorer scores in a number of 
areas: verbal comprehension, perceptual organization, processing speed, and freedom from 
distractibility. Relative percentages also indicated that 41% had lengthened waiting times. 
Reasons for those who experienced lengthened waiting times were attributed to having parents 
who did not recognize the events as seizures, having pediatricians or neurologists miss or defer 
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the diagnosis, and experiencing scheduling problems. Waiting times, for those who experienced 
delay, included 21%  who were diagnosed between one month and four months; 7% who were 
diagnosed between four months and a year; and 13% who were diagnosed over a year later 
(Berg et al., 2014).  
Berg et al (2014) documented waiting time outcomes for seizures as associated with the 
developmental impact of children. A primary weakness in their research is that it takes place in 
a comparatively affluent U.S state (Connecticut) with two large hospitals, seventeen practicing 
specialists, and a state population size of roughly half a million children. Consequently, this 
study was conducted in an environment with better than average access to specialists and the 
results may represent what occurs in optimal situations but not in a majority of other 
geographical environments. The province of Saskatchewan is in a much less ideal state since 
there is only one hospital with a seizure clinic. Further, there are currently only three full-time 
pediatric neurologists and one part-time pediatric neurologist that work at the province’s 
seizure clinic. 
Since the implementation of Berg’s study over twenty years ago, there has been no significant 
change in the clinical pathway in North America (Berg et al., 2014). There is a lack of change in 
the health care system. In order to rise above hurdles regarding access and navigation, an 
unrelenting effort to build and reinforce partnerships between the stakeholders who deliver 
pediatric health care is essential. Through persistent efforts to improve integration, access can 
be improved as the coordination between the hospital setting and the community setting can 
be strengthened.  
An ideal situation for the Saskatchewan pediatric epilepsy clinic would be to mimic a system of 
the development of care pathways such as the system currently implemented in the United 
Kingdom. The United Kingdom’s system urges pediatric neurologists to meet with every child 
patient who presents with a first onset of suspected seizures to be seen within two weeks and 
up to a month of that event as a way to reduce lapsed time between an appointment and the 
event (Berg et al., 2014). This is challenging for a health region with only one seizure clinic and 
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only four pediatric neurologists but it would be largely beneficial in reducing the issues that are 
involved in having a delayed diagnosis such as a poorer seizure outcome and those affecting the 
course of child development. 
The length of time that it takes to wait for a diagnosis from a pediatric neurologist after a 
seizure event can be a critical period for children and families. In our study, this time lapse is 
termed as waiting times and can alter a child’s ability to recover after experiencing their first 
seizure. 
2.5 Seizure outcomes 
Seizure outcome is of interest in our study as it has been shown to lead to better results when 
waiting times for clinical diagnosis and treatment of pediatric epilepsy are minimized. This 
section will provide an understanding of seizure outcome, how it has been defined in the 
literature, and how it will be defined in our study. 
A retrospective study on seizure outcomes in pediatric epilepsy by Dragoumi et al (2013) 
stratified seizure outcomes by dividing the clinical courses of participants into a spectrum of 
four categories describing subjects’ exclusive patterns of clinical course. This classification 
followed the methodology used in an earlier study involving children and adults with newly 
diagnosed epilepsy by Brodie et al (2012). Pattern A: an “excellent” clinical course where 
children became seizure-free early on and remained so during follow-up investigations; Pattern 
B: a delay in seizure freedom for over a year after starting treatment but subjects remained 
seizure-free during follow-up investigations and thus were classified as “improving”; Pattern C: 
a “relapsing” clinical course with periods of seizure freedom lasting more than a year 
interspersed with relapses; and Pattern D: a “poor” clinical course, involved subjects that were 
drug-resistant throughout follow-up investigations, meaning the medicine prescribed was not 
successful in improving the status of their seizure outcome. Under this categorization, 
predictors of an excellent clinical course were those with an early response to antiepileptic drug 
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(AED) therapy and being between ages 6 to 9 years old at the onset of epilepsy. Clinical 
variables identified with a poorer prognosis included association with multiple seizure types, 
young age at seizure onset (within the first year of life), and having an associated history of 
migraines. 
It is evident that studies have defined seizure outcome in various ways. For the purpose of our 
study, seizure outcome will have two possibilities: seizure-freedom (no longer experiencing 
seizures) or experiencing persistent seizures.  
2.6 Potential factors influencing waiting time and seizure 
Many studies have been published on the factors effecting waiting times in pediatric epilepsy. 
The literature review focuses on environment, population characteristics and health 
management. Information on most of these covariates were available for observation in this 
study. This section of the literature review provides an overview of the variables affecting 
waiting time and seizure. 
2.6.1 Patient-Related Characteristics 
Patient-related characteristics include both social demographic factors (factors that make the 
patient susceptible to pediatric epilepsy) and clinical characteristics (factors that influence 
utilization of the pediatric seizure clinic services), both of which characterize the patients 
included in this research. 
2.6.1.1 Social demographic factors 
Research in pediatric epilepsy commonly assesses the effects of social demographic factors. 
These variables are repeatedly studied due to the disparities seen in the number of pediatric 
epilepsy cases seen across various demographics: residence, age, and sex. Each of the variables 
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listed were factors included in our collection of data. A review of these social demographic 
factors is written below.  
2.6.1.1.1 Sex 
Sex-specific incidence rates are consistently higher in males than females. Sex differences in the 
incidence of risk factors for epilepsy could be due to a higher incidence of increased central 
nervous system infection in males (Kotsopoulos et al., 2002).  
2.6.1.1.2 Age at seizure onset 
Seizures can present themselves throughout an individual life course at any given age. Those in 
their first year of life are at the highest risk of experiencing seizures (Dragoumi et al., 2013). The 
literature generally illustrates that an early age of onset coupled with a long duration of 
epilepsy have a dismal influence on the patients’ language and cognitive abilities (Dragoumi et 
al., 2013).  
Age-specific incidence rates show that epilepsy peaks when children are under one year old 
(Epilepsy Canada, 2016). As individuals age, incidence rates gradually decrease and remain low 
until individuals are over 60 years old (Epilepsy Canada, 2016). Older age is documented as a 
protective factor significantly associated with shorter durations of epilepsy (Aguglia, 2011; 
Teutonico et al., 2013). Conversely, studies that included patients of all ages did not 
demonstrate a consistent effect of age at onset on prognosis (Annegers, 1979; Berg, 2001; 
MacDonald, 2000). This is an important demographic factor to consider and as such, in our 




2.6.1.1.3 Age at diagnosis 
Children often have recurring seizures or symptoms once they develop an onset of seizures.  As 
stated previously, this is a risk of recurrence up until the age of 14 years old (Epilepsy Canada, 
2016). In our study, we have taken into account the age of the child subject at the time 
diagnosis. 
2.6.1.1.4 Residence 
Residence, as noted previously, shows much higher incidences and prevalences of pediatric 
epilepsy in developing countries than in developed countries (Guerrini, 2006). The disparities of 
rural and urban locations are also prevalent when it prevents individuals seeking care from 
obtaining the necessary treatment.  
There is a shortage of pediatric neurologists in Saskatchewan and although the population of 
the province has vastly grown in the past twenty years, there has not been much of a 
proportional increase in much of its medical and health care staff. Since our study takes place at 
the only seizure clinic in Saskatchewan, the Royal University Hospital (RUH), we compare 
epileptic children from rural and urban communities within the province in order to gage the 
effects of this factor in the province. 
According to the Canadian Health Commission, geography is a health determinant (Romanow, 
2002). ‘Rural’ and ‘urban’ locations are terms that are commonly used to decipher the 
allocation of resources across provinces. Canada is in a better position than the rest of North 
America because insurance is less of an issue but the characteristics of those in rural versus 
urban dwellings still exist and the shortage of physicians practicing in rural communities is still 
apparent. However, there are specific studies in Canada and abroad that did not find 
differences in the prevalence of epilepsy but did find higher prevalence rates when looking at 
socioeconomic status, even within urban neighbourhoods (Kozyrskyj et al., 2004; Abib et al., 
2007).In our study, we have used rural locations to indicate those residencies located outside of 
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the Saskatoon Health Region (SHR) and urban location to indicate those residencies located 
within the SHR. 
Although Saskatchewan is a relatively expansive province, it encompasses only one seizure 
clinic which is located in the city of Saskatoon. It may be a challenge for some families that 
reside in rural or remote areas of the province to find a means of transportation and 
subsequently find treatment and in some cases, families have to resort to visiting a pediatric 
neurologist in other provinces, particularly those sharing a boundary such as Alberta or 
Manitoba. 
Urban and rural disparities are a reality for many parts of the world including the province of 
Saskatchewan. Rural versus urban health care access is a social dimension that is encountered 
in a wide variety of geographical settings around the globe. Great disparities in access to 
medical services exist between urban and rural populations where urbanized dwellers seem to 
have better access to resources while rural dwellers are deficient in a number of social 
opportunities.   
The Saskatoon Health Region (SHR) represents roughly 5 % of Saskatchewan’s geographical 
boundaries, yet 35 % of those who receive hospital services in the city of Saskatoon live outside 
of the SHR’s geographic land base (Saskatchewan Ministry of Health, 2008). For further 
reference, a map of SHR is displayed in Figure 2.1. One might consider the disparities in health 
care services between those residing in cities within SHR and those outside of SHR can be 
attributed to Saskatoon being the most populous city in the province, yet the population of 




Figure 2.1: Map of Saskatoon Health Region (SHR) 
 
Neudorf et al. (2009) 
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2.6.1.2 Clinical factors 
Research in pediatric epilepsy typically observes the effects of clinical or seizure-related 
variables for an understanding of their impact. These variables are repeatedly studied due to 
the disparities seen in the number of clinical features of epileptic children: seizure type, age at 
seizure onset, seizure frequency, gait, and language. A review of these clinical factors is 
provided below.  
2.6.1.2.1 Seizure type 
There is a challenge involved in defining seizures in a clinical sense because epilepsy is an 
umbrella term that encompasses numerous forms of seizures and symptoms as well as 
presentations. The International League Against Epilepsy (ILAE) has created the classification 
system that is the most commonly used way of defining epilepsy and seizure disorders (ILAE, 
1989). Under the ILAE classification system, two main seizures types are distinguishable: partial 
seizures and generalized seizures. 
Univariate and multivariate analyses have associated seizure type with seizure outcome (Arts, 
1999; Huang et al., 2014; Jayalakshmi et al., 2011; Teutonico et al., 2013). Partial seizures 
usually arise from a limited region of the brain. Partial seizures originate locally in the cortex 
and are typically preceded by a hallucination (of the visual, auditory, or olfactory nature) 
(Kaplan, 2003).  This largely depends on the function of the area of the cortex where the seizure 
takes place.   
As opposed to partial seizure activity which occurs laterally in the brain, generalized seizure 
activity occurs bilaterally (in both the left and right hemispheres of the brain) with 
consciousness abruptly lost; therefore, the patient does not experience a hallucination 
(Chadwick, 1994). Generalized seizures can be either brief experiences or events of longer 




2.6.1.2.2 Seizure frequency 
Seizure frequency is often the term used to assess the activity and severity of epilepsy and the 
efficacy of treatment in obtaining seizure control. This is quantified in different ways in various 
studies of epilepsy (Aldenkamp, 1997). Seizure frequency is an important factor to consider in 
this study because an increased frequency of seizures has proven to interfere with brain 
development (Aldenkamp, 1997).  
Seizure frequency is something typically assessed by all pediatric neurologists and this indicator 
was taken into consideration here. For the purpose of our study, seizure frequency categories 
were divided into those who experienced fewer than 10 seizures total and those who 
experienced more than 10 seizures total to decipher between those with a greater frequency 
and less frequent seizures. The rationale for this is that most children with epilepsy have 10 or 
fewer seizures, thus the division between a low and high frequency (Pellock et al., 2016).  
2.6.1.2.3 Etiology 
Etiology is the term used in pediatric epilepsy to describe the cause of the condition. The 
International League of Against Epilepsy (ILAE) described three categories: 1) 
unidentified/unknown; 2) genetic; and 3) structural/metabolic (Berg et al., 2001) and these are 
also the categories used in our study. An unidentified or unknown etiology means that the 
pediatric neurologist did not identify the etiology in physician notes and the cause is not 
known. A genetic etiology signifies that the origin of the condition comes from a genetic defect. 
Etiologies that are structural or metabolic originate from another structural or metabolic 
condition in which there is an acquired structural abnormality (usually during/prior to birth) or 
genetic where there is a separate condition between the genetic defect and the epilepsy 
condition. In our study, the etiologies of pediatric epilepsy were categorized following the three 





Development is a significant component of functionality and as such, it was a factor observed in 
our study. In particular, gait and language abilities were the components of development 
assessed. 
2.6.1.3.1 Gait 
Gross motor development is essential for daily living. It typically involves larger muscle 
movements of the limbs. Any sport or activity that involves greater movement falls under this 
category.  
Research on motor involvement in children with epilepsy, aged between 7 and 17 years old, has 
shown significant deficits in gross motor and balance capabilities (Kowulski & Di Fabio, 1995).  
Significantly, 19 of the 21 children involved in the study by Kowulski and Di Fabio (1995) with an 
average age of 12.33 years performed below their age-level. These children were assessed on 
their single-leg stance, heel-to-toe walking, and gait.  However, an earlier study conducted by 
Beckung and Uvebrant (1993) on a different sample of children who were epileptic but did not 
have mental retardation or cerebral palsy found only 9 of the 21 epileptic children included in 
the study experienced gross motor impairment. However, static and dynamic balances were 
not assessed in the study by Beckung and Uvebrant (1993). Further, Clement and Wallace 
(1990) found competitive sports were less popular with children who had epilepsy.  Engaging in 
sports requires a great deal of balance and a strong gait, which supports a low desirability to 
engage in sport activity. 
The incidence of new developmental problems of epilepsy in childhood and the variables that 
predict abnormal outcome or deterioration of developmental status have previously 
prospectively been studied at the Royal University Hospital in Saskatoon (Barnard & Wirrell, 
1999). Researchers found that of the 17 children who were developmentally normal before 
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being diagnosed with epilepsy. Significantly, only 11 child patients had a normal presentation at 
follow-up.   
Motor development is a fundamental aspect of human behaviour that is typically required to 
carry out daily functions. Gait is one basic area of gross motor development that pediatric 
neurologists assessed at the Royal University Hospital (RUH), thus, it is the motor development 
variable that has been collected in our retrospective study in order to assess development.    
2.6.1.3.2 Language 
Whether or not a child has appropriate expressive language for their age is one area of 
language that is assessed in seizure clinics. Language development is related to general 
cognitive development and language disorder can be commonly observed in those with 
pediatric epilepsy (Allen et al., 2016; Byars et al., 2013; Karrash et al., 2017; Selassie, 2008; 
Vanasse, 2005; Weiss et al., 2016; Zhao et al., 2014). Expressive language accounts for how 
humans are able to communicate and it is particularly important for children to let parents and 
caregivers understand their needs and emotions.  
Byars et al. (2013), one of those who studied the effects of language in pediatric epilepsy, found 
that children with persistent seizures obtain poorer language scores, even at the onset of their 
seizures when compared to their siblings who do not experience recurrent seizures and peers 
with recurrent but not persistent seizures. Children with epilepsy also continue to show poorer 
language function three years after the onset of seizures even though their healthy siblings and 
children with recurrent seizures demonstrate progression in language skill (Byars et al., 2013).   
Further, researchers have found that children with epilepsy experience other speech 
impairments that cause them to not communicate at a level appropriate for their age. Studies 
demonstrate that children with epilepsy experience pronunciation difficulty (Allen et al., 2016; 
Selassie, 2008; Vanasse, 2005).  Such difficulty in pronunciation may also be problematic when 
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it comes to the demonstration of clear speech. These individuals are often difficult to 
understand because their oral sounds are not clear or precise. 
Zhao et al (2014) found language development can be altered and degenerated in children with 
all types of pediatric epilepsy but those who experience partial seizures from the left 
hemisphere and temporal lobe, which is the area of the brain that controls the comprehension 
of words and speech, have much more difficulty with language than those who have other 
types of epilepsy. 
For the purpose of our study and since there is restricted information that is available given the 
retrospective nature of it, whether or not the child was at the appropriate level of language 
development was the component assessed. This assessment was determined by the pediatric 
neurologist.  
2.6.2 Health management 
In this study, health management involves the way the pediatric seizure clinic services are used 
amongst patients with potential epilepsy. Treatment is the health management that was 
assessed in our study. 
2.6.2.1 Treatment 
There are a number of treatment possibilities available after a diagnosis of pediatric epilepsy 
has been ascertained and that treatment is necessary for the patient, including 
pharmacotherapy, ketogenic diet, vagus nerve stimulation, and surgery (Benbadis & Tatum, 
2001). The three types of treatments that were collected in our study were antiepileptic drugs 
(AEDs), ketogenic diets, and surgeries. As a result, these are the three types of treatments that 
will be discussed in this literature review. 
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2.6.2.1.1 Anti-epileptic drugs (AEDs) 
AEDs, or anticonvulsants, are a group of medications that help to control the frequency and 
severity of seizures (Kaiser, 2002; Lamberink, 2017). AEDs are the most widely-used form of 
treatment for pediatric epilepsy. However, this treatment type is not without its problems 
which include its effectiveness, compliance in the use of drugs as prescribed, and the side-
effects that can result through intake. Previous studies show that response to the first drug is 
directly associated with seizure outcome (Dlugos et al., 2001; Kwan & Brodie, 2010; Schiller & 
Najjar, 2008; Sillanpää, 1993).   
The goal of treatment in using AEDs is to reduce seizure frequency and enhance a patient’s 
well-being with as few side effects, complementary medications, and long-term detrimental 
effects as possible. Most neurologists recommend waiting until after a child has had a second 
seizure before starting that child on AED therapy as confirmation that drug intervention is 
necessary (Miller & Drislane, 2007). There are, however, times when the risk of recurrent 
seizures is higher (such as with a tumor or infection) and immediate AED treatment may be 
warranted. However, a second seizure confirms that the risk of recurrence is greater and 
treatment with AEDs is typically necessary and signaled by such an event (Miller & Drislane, 
2007). 
Prospective studies that observed epileptic children from the onset describe most patients as 
seizure-free within the first few years of epilepsy (Oostrom et al., 2005; Shinnar & Pellock, 
2002). AEDs tend to provide effective treatment for most children and can drastically help with 
seizure control. Nearly two-thirds of patients are able to end consumption of medication after 
they become seizure-free.  However, 20%-30% of epileptic children are unaffected by AEDs and 
continue to experience seizures (Mikati at al., 2010; Johnson et al., 2011). Seizures do not 
always last beyond childhood, but there is evidence that pediatric epilepsy is associated with 
adverse long-term psychosocial outcomes, even in those who no longer have the condition 
(Shinnar & Pellock, 2002).  
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The number of AEDs a child receives is thought to impact their developmental and cognitive 
functioning (Elger et al., 2004; Bulteau et al., 2000). As such, in our study, We have collected 
data including the number of AEDs a child was taking before their first clinic visit at the Royal 
University Hospital (RUH) and the number of AEDs they were prescribed across the history of 
their epilepsy. 
2.6.2.1.2 Ketogenic diet 
A ketogenic diet, also known as a high-fat and low-carbohydrate diet, is a therapeutic 
alternative that is often considered when an epileptic child is resistant to anti-epileptic drug 
(AED) therapy or parents choose to not treat their child with drugs (Greener, 2014). As with any 
change to a diet, this form of treatment can be difficult to introduce to the regimen of any 
individual and there are further challenges to regularly maintain the diet in a personally suitable 
way. Additionally, this form of the diet requires a fairly high level of support from health care 
specialists (Reading, 2010). However, this diet can be the right form of therapy for a child with a 
high frequency of seizures and it has proven to be an effective method for many epileptic 
children.  
Ketogenic diets can involve a great deal of maintenance and monitoring, more than other 
treatment methods, for a family but are still a widely preferred method for patients have tried 
AEDs without success or do not want the drug intake to begin with. For those children who 
remain on the diet and achieve greater than a 50% reduction in seizures, a ketogenic diet is 
recommended to be continued for a minimum of two years, similarly to AEDs (Sharma & Jain, 
2014). Ketogenic diets can either be weaned immediately in cases of emergency or more slowly 
over weeks or months by reducing the ratio gradually in those who have been treated for years 
(Sharma & Jain, 2014).  
The efficacy of a ketogenic diet is better than most of the new AEDs and is more feasible for 
families without a drug plan (Sharma & Jain, 2014). It should be considered in patients with 
refractory epilepsy, after the failure of two or three appropriately attempted anti-epileptic 
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drugs (AEDs). However, in general, half the patients treated with a ketogenic diet will have at 
least a 50% reduction in the seizure frequency of child subjects with refractory epilepsy 
(Sharma & Jain, 2014). Since many patients find it difficult to maintain this diet, individuals 
usually opt to discontinue it if they do not experience any benefit. Ketogenic diets result in 
shorter or medium term benefits in seizure control, the effects of which are comparable to 
modern AEDs.   
It has been suggested that developmental improvements of varying degrees can be witnessed 
from those individuals who follow a ketogenic diet (Zhu et al., 2015; Pulsifer, 2001). These 
developmental improvements include fundamental areas of functioning such as language use 
and gross motor movement.  
2.6.2.1.3 Surgery 
Surgery can be an effective method for treating epilepsy (Freitag & Tuxhorn, 2005; Jayalakshmi 
et al., 2014; Maehara & Shimizu, 2001; Sunaga et al., 2009). It involves a referral from the 
pediatric neurologist to the neurosurgeon. Surgery may be the best option for drug-resistant 
patients and individuals who are showing no improvement after changing to a ketogenic diet 
(Jayalakshmi et al., 2014). This treatment method is typically considered after two or three 
attempts of anti-epileptic drug (AED) treatment that show no improvement. Decades ago, 
surgery was not as readily considered an option for individuals and families but now with 
increasing modern technology, surgery is becoming a more readily used method of treatment 
for pediatric epilepsy. A major encouraging factor of this treatment method is that many 
individuals who undergo surgery are able to discontinue their intake of further AED medication.   
Research suggests that surgery affects child development in a number of ways including in the 
ways of language development and verbal memory (Jayalakshmi et al., 2014). There is strong 
evidence of the decline of verbal memory as far in advance as up to two years after a left 
temporal lobectomy which improves with time (Alpherts et al., 2006). Studies demonstrate an 
improvement in motor function, regardless of whether epileptic episodes were no longer 
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experienced or whether seizure frequency of the patient had decreased (Beckung et al., 1994; 
Romanelli et al., 2001; Krsek et al., 2002). Further, other researchers have found motor 
deterioration to be a common risk of epilepsy surgery (Chassoux et al., 1999; Graveline et al., 
1999). With all the risks and complications involved in epilepsy surgery, it has generally been 
concluded that about 70% of those who have this form of treatment eventually become 
seizure-free (Freitag & Tuxhorn, 2005; Jayalakshmi et al., 2014; Maehara & Shimizu, 2001; 
Sunaga et al., 2009). 
2.7 Summary 
In summary, pediatric epilepsy plays a significant role in how development is affected in a child 
with the illness. It can be assumed from the studies in this literature review that seizures 
experienced throughout childhood influence developmental delay in various ways and waiting 
times can further provoke these delays. Reducing waiting times for children who experience 
suspected seizures would help in reducing developmental problems of the developing brain. In 
order to perceive a full understanding of this issue, it is important to recognize the actual 
process of regression beginning from the stage of diagnosis throughout follow-up 
investigations. Taking all of these studies into account will provide an understanding of the 
process as a whole and will complement the understanding of social equity. Given the 
prevalence and incidence of pediatric epilepsy in Canada and Saskatchewan, waiting time is an 




CHAPTER 3: METHODOLOGY 
3.1 Overview 
This chapter describes the conceptual model that will be used to guide this research. Data 
collection methods and procedures will also be discussed in this section. Characteristics of the 
participants, such as inclusion and exclusion criteria, and sampling considerations such as 
sampling scheme and sample size are reviewed in this section.  The research design for the 
study is discussed, as well as the statistical analyses that will be conducted to address the 
research questions.  
3.2 Theoretical perspective and conceptual model 
This section provides a brief introduction into the theoretical perspective and conceptual model 
that will frame this study. The theoretical perspective provides information as to the ideology 
that explains health, while the conceptual model provides the operationalization of the theory 
for this study. The theoretical perspective that will be used to guide this research is a 
sociobehavioural or environmental perspective. This will help explain the use of health care 
services by taking social demographic factors, clinical factors, health management, health 
outcome (waiting time) and its impact on seizure outcome into account. Observing the 




The development of the conceptual model of our study is exemplified in Figures 3.1 and 3.2. 
Figure 3.1 is the Andersen Model of Health Care Utilization (1995). Andersen’s model displays 
environment, population characteristics, and health management as the three domains of 
importance in health care use. Environment includes the health care system and is interrelated 
with population characteristics which include predisposing characteristics, enabling resources, 
and need characteristics of the individuals using the health care services. Health management 
involves personal health choices as related to the use of health services and is also interrelated 
with population characteristics.   




The Andersen Model of Health Care Utilization evolved into the Andersen Behavioral Model of 
Health Services Use (Figure 3.2).  The evolved model includes health outcomes which we have 
included in our proposed conceptual model. This involves the perceived health status of 
individuals, their evaluated health status (usually by a health care practitioner), and consumer 
satisfaction. 




In this study, the proposed conceptual model exemplified is shown in Figure 3.3 as an extension 
of Andersen’s model.  
Figure 3.3: Proposed conceptual model as modified Andersen behavioural model 
 
The model depicted in Figure 3.3 has been altered from Andersen’s original model but still 
displays four main domains: patient-related characteristics (i)social demographic factors and ii) 
clinical factors), iii) health management, and iv) health outcome with the addition of impact. 
The interconnectedness between these factors will be assessed.  
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The social demographic factors of our study include the age at seizure onset, sex, the age that 
the child is at diagnosis, and residence which is either an urban or rural location in the province 
of Saskatchewan. The clinical factors of our study include the type of seizure the child 
experienced, etiology, the seizure frequency experienced, gait, and language skills. In our study, 
health management are the treatments available at the pediatric seizure clinic including: anti-
epileptic drugs (AEDs), ketogenic diet, or surgery.  
The health outcome in our study is waiting time and we are also interested in the impact this 
has on seizure outcome by looking at two possibilities of it: seizure-free - no longer having 
seizures at follow-up clinic appointments and not seizure-free - continuing to have seizures at 
follow-up clinic appointments. All of the main domains and factors within this depicted model 
work together in identifying the need for medical attention, understanding the treatment 
required, and the wait times leading up to the pediatric seizure clinic services. 
3.3 Study design 
This is a retrospective population-based study. Data collection consisted of data extraction from 
the medical charts of patients with pediatric epilepsy who attended the pediatric seizure clinic 
at the Royal University Hospital (RUH) in Saskatoon, Saskatchewan, Canada.  
3.4 Inclusion/exclusion criteria 
All children who visited the pediatric seizure clinic at the Royal University Hospital (RUH) from 
2012-2015 were considered for this study. One child was not assessed for eligibility because 
they did not have health insurance and therefore, there was no way to link their record with 
the Saskatoon Health Region (SHR)’s electronic database. Inclusion and exclusion criteria that 
were considered in this study are summarized in this section. This particular time range (years 
2012-2015) was chosen because those diagnosed more recently tended to have more complete 
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records in their medical charts and the electronic medical system was more widely used at the 
SHR during this time range.  
3.5 Inclusion criteria 
The inclusion criteria that were pertinent in the execution of this study included the following: 
 Patients at the seizure clinic of Royal University Hospital located in Saskatoon, 
Saskatchewan; 
 All patients with a first clinic appointment between January 1 2012 and December 31 
2015; 
 Patients diagnosed with partial or generalized seizures; 
 A diagnosis of epilepsy confirmed by a pediatric neurologist;  
 Age of child ≤17 years old at the time of the study;  
3.6 Exclusion criteria 
The exclusion criteria that were considered in the implementation of this study included the 
following: 
 Children who were not diagnosed at the Royal University Hospital seizure clinic in 
Saskatoon; 
 Children who were not diagnosed with epileptic seizures as determined by a pediatric 
neurologist; 
 Children ≥ 18 years at the time of diagnosis; or 




3.7 Sample, participants, and population 
3.7.1 Study population 
Saskatoon is the most populous urban center in the province, located in central Saskatchewan, 
Canada. Saskatoon’s population is composed of 17.9% individuals under the age of 15 years 
(18.7% males and 17.2% females) and historically is one of the provinces in Canada with the 
youngest age demographics (Statistics Canada, 2012). The population under study in this 
research project consisted of children aged 0 – 17 years old residing within the province of 
Saskatchewan.  
3.7.2 Sampling and participants 
A convenient sampling scheme was used in this study because it was the most practical form of 
gathering participants since epilepsy is fairly low in incidence. The accessibility of participants 
due to geographical location was another reason for the recruitment of this pool. The 
population was pre-determined by the electronic health records database at the Saskatoon 
Health Region (SHR). 
The Royal University Hospital (RUH), located in Saskatoon, is the only site in the province of 
Saskatchewan that is specialized in pediatric epilepsy care for individuals that are under 18 
years old.  
The sample for this study started with 1158 children, gathered from the Royal University 
Hospital (RUH) in Saskatoon, Saskatchewan. Each child included in this study had an 
appointment with a pediatric neurologist at the seizure clinic between January 1, 2012 and 
December 31, 2015. After considering all of the inclusion criteria, the sample size was 197 




Figure 3.4: Study flow diagram of epileptic patients seen between January 1, 2012 and 




3.8 Ethics approval 
This study required approval by both the research ethics review boards of the SHR and the 
University of Saskatchewan since each of these boards partnered in making this research 
possible. Approval to carry out the study was obtained from the University of Saskatchewan 
(Bio # 15-238) research ethics review board. Permission to collect data was also obtained from 
the Saskatoon Health Region (SHR) research ethics review board. Approval processes for both 
organizations occurred in the final quarter of 2015.  
3.9 Data collection statistical methods 
3.9.1 Data collection 
Data collection first began with those individuals who were diagnosed earliest in 2012 and was 
chronically collected forward up until the collection of those who were diagnosed in 2015. The 
measurement tool that we used to conduct this study was the electronic medical records of the 
Saskatoon Health Region (SHR). The data collected at this site was directly recorded into an 
excel dataset that was password-protected and saved on an encrypted USB device.  
A total of 24 variables were taken into account during the analysis phase, according to the 
study hypothesis. Data items included information on demographics (age, sex, residence), 
epilepsy diagnosis data (date of epilepsy diagnosis), date of referral to the Royal University 
Hospital (RUH) seizure clinic, epilepsy presentation (seizure frequency, seizure type, symptoms 
experienced), past medical history (family, social, birth), epilepsy treatment, medical and 
neuro-imaging examinations (neurological examinations, MRI, and EEG readings). 
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3.9.2 Data collection variables 
The independent variables that were analyzed in the course of this study are summarized in 
Table 3.2. A total of 17 variables were not included in the analysis either because they were 
believed to be irrelevant to the results, they had little analytical value for the study as they 
were not commonly documented from the clinical visits, or not enough cases had reported the 
information. Several of the variables that were collected were not consistently identified across 
the physicians onsite, thus many physicians did not record this information in their patient 
notes. 
3.9.3 Variable selection 
3.9.3.1 Independent variables 
In order to perform this research and the analysis, a number of independent or causal variables 
were collected. These variables are listed in Table 3.2 and were selected to be incorporated 
based on the information that was available in the electronic medical records. The environment 
and population characteristics included variables that were either available regarding personal 
information or were available variables that were recorded by the pediatric neurologist at 
patient appointments.   
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Various baseline characteristics including social demographic factors, clinical factors, health 
management, health outcome, and impact of the sample are listed in Table 3.1.  These 
characteristics include the age of participants, age at seizure onset, sex, residence, seizure type, 
etiology, development, waiting time, follow-up time at the pediatric seizure clinic, and seizure 




Table 3.1: Baseline characteristics of study sample (N=197) 
Variable Mean (± SD); N (%) 
Mean Age at Diagnosis (years) 6.2 (±5.2) 
Mean Age of Seizure Onset (years) 5.60 (±5.1) 
Female (%) 90 (46%) 
Rural Location (%) 120 (61%) 
Epilepsy Type  
                             Partial (%) 136 (69%) 
Generalized (%) 61   (31%) 
Etiology  
                             Unidentified 89 (45%) 
                             Genetic 70 36%) 
                              Structural 38 (19%) 
Development  
                             Abnormal Gait 24 (12%) 
                            Abnormal Language Skills 38 (19%) 
Treatment  
                           Anti-epileptic Drugs 196 (99%) 
                           Ketogenic Diet 21 (11%) 
                           Surgery 7 (4%) 
Mean Waiting Time (months) 4.33 (±3.6) 
Mean Follow-Up Time (months) 20.9 (±11.0) 
Seizure-free 132 (67%) 
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The independent variables used in this analysis are listed and summarized in Table 3.2. This list 
of variables was chosen as identified by the literature review and based on their influence 




Table 3.2: Independent variables used in data analysis   





   
 
Age At time of study Continuous 
 
Sex Male/Female Categorical 
 
Age at seizure onset At diagnosis Continuous 
 
Residence Name of residing city/town Categorical 
Clinical factors 
   
 
Type of seizure(s) Partial/General Categorical 
 
Seizure frequency 0-99 Categorical 
 
Etiology identified at last visit Yes/No Categorical 
 
Etiology   Genetic/Structural/Unknown Categorical 
 
Gait Walk/Unable to walk Categorical 
 
Language Age appropriate/Not age appropriate Categorical 
Health management 
Treatment 
   
 
Number of AEDs before first clinic 0-99 Categorical 
 
Number of AEDs historically 0-99 Categorical 
 
Surgery Yes/No Categorical 
 
Ketogenic diet Yes/No Categorical 
 
MRI results Normal/Abnormal Categorical 
 
Date of first EEG results Date Categorical 
 
EEG results Normal/Abnormal Categorical 
 
EEG telemetry performed Yes/No Categorical 
Health outcome 
Waiting time    
 Duration of waiting time Number of months Categorical 
 Date of referral to seizure clinic Date Categorical 
 Date of first clinic visit Date Categorical 
 Number of clinic visits 0-99 Categorical 
 Follow-up time Number of months Categorical 
Impact 
Seizure outcome    
 Seizure outcome Seizure-free/not seizure-free Categorical 
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3.9.3.2 Dependent variable 
The outcome or dependent variable of interest in this study was waiting time. We were 
interested in how the period of time between a first seizure occurrence and a first clinic 
appointment impacts the seizure outcome. This variable was distributed into two 
distinguishable categories and it is defined in the following ways: 
1) Seizure-free: the study participant experienced no further seizures as identified in the 
last six months and as identified by a pediatric neurologist on clinic follow-up 
appointments; and 
2) Not seizure-free: the subject continued to experience seizures as confirmed by a 
pediatric neurologist after the subject’s first clinic visit as identified at follow-up 
appointments. 
3.9.4 Risk factors and protective factors for waiting time in pediatric epilepsy 
There are a number of factors which can contribute to the clinical course of waiting time. This 
study focuses on risk factors and protective factors. Risk factors are elements that increase the 
risk or likelihood of an individual being affected by lengthened waiting times in pediatric 
epilepsy. Conversely, protective factors are those that reduce the likelihood of lengthened 
waiting times.  
Risk factors can influence seizure outcomes in a number of ways. The more risks a child is 
exposed to, the greater the likelihood they will experience either lengthened waiting times in 
pediatric epilepsy or a less desirable seizure outcome. These risk factors include rural residency, 
young age at seizure onset (<1 year old), and development. Protective factors help in reducing 
the likelihood of lengthened waiting times and include such factors as urban residency, older 
age at onset and age-appropriate development.  
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3.9.5 Data analysis procedures 
The data was cleaned by checking the distribution of variables. The data was also checked for 
potentially incorrect values during this process. The data was categorized based on the 
frequencies of variables. 
3.9.6 Descriptive analysis 
Descriptive statistics were computed using the information on population characteristics that 
was collected on patients who were eligible for analysis in our study. Descriptive data involved 
categorical data from patient-related characteristics such as the social demographic data (age, 
sex, residence) and the clinical characteristics (type of seizure, seizure frequency, etiology, etc.), 
summarized in frequencies, percentages and proportions. This analysis also included data from 
health management (treatment use), health outcome (waiting time), and the impact (seizure 
outcome).  
3.10 Logistic regression analyses 
Fixed covariates were the only variables included in the logistic regression models. Such 
covariates included environment, population characteristics, and health manamgent. Potential 
factors that were tested and included in the multivariate models include age diagnosis, age at 
seizure onset, sex, residency, type of seizure, waiting time, development (gait and language 
skills) and treatment use methods as was determined through the literature review.  
The analysis of this study was intended to address the two objectives that were identified in the 
first chapter of this paper:  




2) It further identified any possible risk factors that were associated with waiting times 
that lead to seizure outcome by checking the interaction of variables that were 
observed 
Logistic regression analysis was used in order to calculate adjusted Odds Ratios (AOR) and 95% 
Confidence Intervals (95% CI). 
3.10.1 Odds ratio and 95% confidence interval 
The odds ratio (OR) was calculated in the analysis to show how much more likely it is that 
someone who is exposed to the factor under study will continue to have epilepsy as compared 
to someone who is not exposed to the factor. According to the results, there were many factors 
that played a role in seizure outcome. These factors will be discussed in the sections that 
follow.  
3.10.2 Univariate analysis  
To control the effect of confounders, univariate analysis of variance which includes regression 
analysis was used for all variables that were found to have any significant differences to check 
for confounders.  
Univariate logistic regression analysis techniques were utilized to examine the relationship 
between each predictor/potential risk factor as outlined in the literature review and the seizure 
outcome, whether the patient was seizure-free for a period within 6 months, 12 months, and 
18 months. The purposeful selection process began by conducting a univariate analysis of each 
variable. 
The level of significance that was used for tests of univariate logistic regression analyses were 
set to .05 (α = .05). 
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3.10.3 Multivariate analysis 
The multivariate model was built based on the values of the results that were calculated from 
running the univariate model analysis. All variables that were less than .20 from the univariate 
analyses were included in the multivariate models. 
The multivariate logistic regression analysis was performed by adding each of the significant 
factors from the conceptual model to the model of analysis in order to see whether they were 
significantly associated with the seizure outcome of the child patients who were included in this 
study. The significance of these results was then calculated to determine factors of collective 
value in our study.  
The level of significance used to perform the multivariate logistic regression analyses was set to 
.05.  
3.10.4 Interaction 
Interaction terms between seizure outcome and each of the significant covariates according to 
the multivariate logistic regression analyses were assessed. The level of significance for 
interaction terms was .05.  
3.10.5 Software 
Microsoft Excel was utilized to input all data collected through electronic medical chart review 
from the Saskatoon Health Region (SHR) database and all analyses were generated through the 
use of SPSS version 23.0 for this study. 
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CHAPTER 4: RESULTS 
4.1 Overview  
The analysis in this section was restricted to the 197 child participants with epilepsy that were 
involved in this study. The results described are addressed according to the four research 
questions. 
4.2 Patient-related characteristics 
Social demographic factors 
The number of female subjects was 90 (46% of subjects) and the number of male subjects was 
107 (54% of subjects). 
The social demographic factors of this sample confirm that the mean age at seizure onset was 
5.6 years old (SD=±5.0). The mean age at the time of diagnosis was 6.2 years (SD =±5.2).  
The distribution of residence in this study shows that 61% of subjects lived in a rural 
environment (within the Saskatoon Health Region (SHR)) and 39% of subjects resided in an 




In terms of the clinical presentation that subjects displayed at appointments, 31% of subjects 
had a general epilepsy presentation and 69% had a partial epilepsy presentation. All of the 
subjects were treated with clinical care at the seizure clinic in the Royal University Hospital of 
Saskatoon. 
In terms of the seizure frequency experienced within the sample population, 26% presented 
with less than 10 seizures and 74% of subjects presented to the hospital with more than 10 
seizures. 
In terms of language and motor development, 12% of subjects presented with gait that was not 
age-level appropriate and 19% of subjects presented with language that was not age-level 
appropriate. 
Health management - Treatment 
In terms of the treatment sought, 95% of subjects were treated with anti-epileptic drugs 
(AEDs), 4% of subjects were treated with surgery, and 11% of subjects were treated with a 
ketogenic diet.  
Amongst the sample population, the average number of clinic visits by patients at the Royal 
University Hospital (RUH)’s pediatric seizure clinic was 4.3 (±2.5) with the fewest number of 
visits being 1 and the most frequent number of visits being 24 throughout the clinical course of 
the patient. 
The average follow-up time of those using the services at RUH’s pediatric seizure clinic was 20.9 
months (±11.0) with the 2.4 months as the shortest follow-up time and 54 months as the 
longest follow-up time. 
Health outcome – Waiting time 
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The mean duration of waiting time for a first clinic appointment was 4.3 (±3.6) months. The 
range for waiting time that subjects experienced was between 0 months through 24 months. 
Impact – Seizure outcome  
At the last seizure assessment, 132 patients were identified as seizure-free and 65 patients 
were identified as not seizure-free. 
4.2.1 Differences by seizure outcome 
Descriptive analysis was performed to characterize the variables and their distributions in the 
data; these results are presented in Table 4.1 and categorized by seizure outcome. Additionally, 
p-value is displayed. The descriptive statistics were computed for all information on the eligible 
subjects that were used to complete this analysis.  
Of the 65 that were classified as not being seizure-free, 54 (83%) experienced more than 10 
seizures, while among the 132 seizure-free, 91 (69%) experienced more than 10 seizures 
(p=0.034).  
Slightly more subjects that were not seizure-free experienced gait problems 13 (20%) when 
compared to those who were seizure-free 11(8%; p=0.018). Additionally, 19 (29%) of those who 
were not seizure-free experienced language difficulties while 19 (14%) of those who were 
seizure-free experienced language difficulties (p=0.013).  
Subjects who were not seizure-free experienced had a mean waiting time of 3.5 months 
(SD=3.7) while subjects who were seizure-free had a mean waiting time of 4.7 months (SD=3.2).  
The data showed that there was a difference in waiting time between patients who were 




Table 4.1: Study characteristics stratified by seizure outcome (N=197) 
  
Seizure-free Not seizure-free p-value 
(n = 132) (n = 65) 
Patient-related characteristics 




Male 74 (56%) 33 (51%) 




Urban 49 (37%) 28 (43%) 
 Rural 83 (63%) 37 (57%) 
 Age at epilepsy onset, y 5.5 (±5.0) 6.1 (±5.0)                  .43 





Partial 90 (68%) 46 (71%) 
 General 42 (32%) 19 (29%) 
 Seizure Frequency 
  
.03 
<10 41 (31%) 11 (17%) 
 >10 91 (69%) 54 (83%) 
 Gait not age-appropriate 11 (8%)         13 (20%) .02 




     Unidentified      56 (42%) 33 (51%) 
      Genetic 49 (37%) 21 (32%) 
      Structural 27 (20% 11 (17%) 
 Health management 
Treatment 
   Number of AEDs 
   Total 1.8 (±1.3) 1.9 (±1.3) .34 
Before first clinic 0.64 (±0.7) 0.52 (±0.8) .38 
Surgery 6 (5%) 1 (2%) .29 
Ketogenic Diet 13 (10%) 8 (12%) .60 
Health outcome 
Waiting time 
Mean number of visits 4.3 (±2.2) 3.7 (±1.6) .39 
Mean waiting time, m 3.5 (±3.2) 4.7 (±3.7) .01 
Mean follow-up duration, m 20.9 (±10.0) 20.2 (±12.5) .86 
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4.2.2 Differences by residence 
Descriptive analysis was performed to characterize the variables and their distributions in the 
data; these results are presented in Table 4.2 and categorized by residence. Additionally, p-
value is displayed. The descriptive statistics were computed for all information on the eligible 
subjects that were used to complete this analysis.  
Of the 77 that were from a rural residence, 5 (6%) had language difficulties whereas 33 (28%) of 
the 120 subjects from an urban residence had a language difficulty. The data showed there was 
a difference between rural and urban residents in language difficulty (p <.0001). 
Of the rural residents, the mean number of anti-epileptic drugs (AEDs) before the first clinic was 
0.4 (SD=0.7) whereas the mean number of AEDs for urban residents was 0.7 (SD=0.8). The data 
showed a difference between rural and urban residents in number of anti-epileptic drugs taken 
before the first clinic visit (p<0.001).  
The mean waiting time for rural residents was 5.5 months (SD=3.7). Urban residents had a 
significantly shorter mean waiting time of 3.6 months (SD=3.0). The data showed a difference 




Table 4.2: Study characteristics stratified by residence (N=197) 
  
Urban Rural 
                 p-value 
(n = 120) (n = 77) 
Patient-related characteristics 
    
0.35 
Social demographic factors 
Sex 
Male 62 (47%) 45 (69%)   
Female 58 (44%) 32 (49%)   
Age at epilepsy onset, y 5.6 (±5.1) 6.3 (±4.9)                  0.9 





Partial 77 (58%) 56 (86%)   




<10 32 (24%) 20 (31%)   
>10 88 (67%) 57 (88%)   
Gait not age-appropriate 19 (16%)           5 (6%) 0.05 




    Unidentified 52 (43%)        37 (48%)   
    Genetic 44 (37%)         26 (34%)   
    Structural 24 (20%)         14 (18%)   
Health management 
  
  Treatment 
Number of AEDs 
  
  
Total 2.0 (±1.2) 1.7 (±1.3)                  0.06 
Before first clinic 0.7 (± 0.8) 0.4 (±0.7) <.0001 
Surgery 6 (5%)           1 (1%) 0.17 
Ketogenic Diet 15 (13%) 6 (8%) 0.3 
Health outcome 
4.4 (±2.8) 4.2 (±1.9)                  0.41 Waiting time 
Mean number of visits 
Mean waiting time, m 3.6 (±3.0) 5.5 (±3.7) <.0001 







    Seizure-free 49 (37%) 28 (43%) 
      Not seizure-free 83 (63%) 37 (57%) 
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4.2.3 Differences by motor development 
Descriptive analysis was performed to characterize the variables and their distributions in the 
data; these results are presented in Table 4.3 and categorized by abnormal or normal motor 
development. Additionally, p-value is displayed. The descriptive statistics were computed for all 
information on the eligible subjects that were used to complete this analysis.  
Of the 24 subjects who did not have age-appropriate motor development, 15 (63%) were also 










(n = 173) (n = 24) 
Patient-related characteristics 
    
  
Social demographic factors   
Sex 0.39 
Male 92 (53%) 15 (63%)   




Urban 101 (58%) 19 (79%)   
Rural 72 (42%) 5 (21%)   
Age at epilepsy onset, y 5.9 (±5.0) 5.3 (±4.9) 0.50 




Seizure type 0.05 
Partial 121 (70%) 12 (50%)   




<10 44 (25%) 8 (33%)   
>10 129 (75%) 16 (67%)   




    Unidentified 82 (47%)        7 (29%)   
    Genetic 59 (34%)         11 (46%)   
    Structural 32 (19%)         6 (25%)   
Health management 
  
  Treatment 
Number of AEDs 
  
  
Total 2.0 (±1.3) 1.6 (±0.7) 0.13 
Before first clinic 0.6 (±0.8) 0.4 (±0.6) 0.24 
Surgery 7 (4%) 0 (0%) 0.32 
Ketogenic Diet 18 (10%) 3 (0%) 0.76 
Health outcome 
4.3 (±2.6) 3.8 (±1.6) 0.71 Waiting time 
Mean number of visits 
Mean waiting time, m 4.4 (±3.5) 4.5 (±2.7) 0.54 




    Seizure-free 49 (37%) 28 (43%) 
  
    Not seizure-free 83 (63%) 37 (57%) 
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4.2.4 Differences by language development 
Descriptive analysis was performed to characterize the variables and their distributions in the 
data; these results are presented in Table 4.3 and categorized by language development. 
Additionally, p-value is displayed. The descriptive statistics were computed for all information 
on the eligible subjects that were used to complete this analysis.  
Of the 38 that experienced language difficulties, 27 (71%) were male while 11 (29%) were 
female. The data showed that there were differences between those that were age-appropriate 










(n = 159) (n = 38) 
Patient-related characteristics 
    
  
Social demographic factors   
Sex 0.02 
Male 80 (50%) 27 (71%)   




Urban 87 (55%) 33 (87%)   
Rural 72 (45%) 5 (13%)   
Age at epilepsy onset, y 6.0 (±5.1) 4.7 (±4.8)                  0.24 
Age at diagnosis, y 6.6 (±5.2) 5.6 (±5.0) 0.12 
Clinical characteristics 
  
0.07 Seizure type 
Partial 112 (70%) 21 (55%)   




<10 45 (28%) 7 (18%)   
>10 114 (72%) 31 (82%)   




    Unidentified 74 (47%) 15 (39%)   
    Genetic 55 (35%) 15 (39%)   
    Structural 30 (18%) 8 (22%)   
Health management 
  
  Treatment 
Number of AEDs 
  
  
Total 1.9 (±1.3) 0.6 (±0.8) 0.95 
Before first clinic 1.8 (±1.1) 0.6 (±0.6) 0.58 
Surgery 6 (4%) 1 (3%) 0.73 
Ketogenic Diet 17 (11%) 4 (11%) 0.98 
Health outcome 
4.4 (±2.7) 4.0 (±1.5) 
  
Waiting time   
Mean number of visits 0.37 
Mean waiting time, m 4.4 (±3.5) 3.9 (±2.8) 0.36 




    Seizure-free 49 (37%) 28 (43%)   




4.2.5 Differences by sex 
Descriptive analysis was performed to characterize the variables and their distributions in the 
data; these results are presented in Table 4.5 and categorized by sex. P-value displays the 
significance of the covariate. The descriptive statistics were computed for all subjects based on 
the information available.  
Of the 91 child patients that were female, the mean number of anti-epileptic drugs (AEDs) was 
1.7 (SD=1.1) whereas the mean AEDs for males was 2.1 (SD=1.4). The data showed that there 
were differences in the total number of AEDs between males and females (p=0.05).  









(n = 132) (n = 65) 
Patient-related characteristics 




Urban 63 (59%) 57 (63%)   
Rural 43 (41%) 34 (37%)   
Age at epilepsy onset, y 6.2 (±5.1) 5.8 (±4.9)                  0.23 





Partial 74 (70%) 59 (65%)   




<10 23 (22%) 29 (32%)   
>10 83 (78%) 62 (68%)   
Gait not age-appropriate 13 (12%)         11 (12%) 0.98 




     Unidentified      46 (43%) 43 (47%)   
     Genetic 40 (38%) 30 (33%)   
     Structural 20 (19%) 18 (20%)   
Health management 
  
  Treatment 
Number of AEDs 
  
  
Total 2.1 (±1.4) 1.7 (±1.1) 0.05 
Before first clinic 0.58 (±0.7) 0.60 (±0.8) 0.86 
Surgery 2 (2%) 4 (4%) 0.07 
Ketogenic Diet 12 (11%) 9 (10%) 0.75 
Health outcome 
4.3 (±2.5) 4.4 (±2.5) 0.84 Waiting time 
Mean number of visits 
Mean waiting time, m 4.5 (±4.1) 4.4 (±3.3) 0.8 




    Seizure-free 73 (69%) 59 (65%)   
    Not seizure-free 33 (31%) 32 (35%)   
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4.2.6 Waiting time 
Figure 4.1 below displays the waiting time experienced by pediatric epilepsy patients who 
attended the seizure clinic for diagnosis between 2012 and 2015.  
Although there was a rise in the average waiting time in 2014, the number of patients also 
doubled from 2012. The number of pediatric neurologists steadily increased from 1 to 4 within 
the study period. In 2015, the shortest waiting times were observed and the clinic was staffed 
with the highest number of pediatric neurologists within the study period. 







































4.3 Logistic regression 
Logistic regression models were performed to identify the independent determinants of seizure 
outcome. All predictor variables analyzed were used as predictors in the logistic regression 
model. These included covariates from the conceptual model: external environment, 
population characteristics, health management, health outcome, and impact. Univariate 




4.3.1 Univariate logistic regression 
Table 4.6: Univariate logistic regression results for prediction of seizure outcome within 6 
months (N=197) 
Variable  OR    95% CI p-value 
Sex       
   Male 1     
   Female 1.14 0.65 - 2.00 0.65 
Age at seizure onset 1.01 0.95-1.07 0.79 
Age at diagnosis 1.03 0.51-1.09 0.34 
Residence       
   Urban 1     
   Rural 1.39 0.78-2.47 0.26 
Gait       
   Age-appropriate                  1     
   Not age-appropriate              2.96 1.17-7.50 0.02 
Language skills       
   Age-appropriate                      1     
   Not age-appropriate            2.13 1.02-4.41 0.04 
Type of epilepsy       
   Partial 1     
  General 0.70 0.38-1.27 0.24 
Etiology       
   Unidentified      1     
   Genetic 0.80 0.36-1.75 0.57 
   Structural 1.02 0.48-2.19 0.95 
Number of AEDs before first clinic 0.92 0.65-1.32 0.66 
Total number of AEDs 1.09 0.87-1.37 0.45 
EEG 0.65 0.36-1.19 0.16 
Ketogenic diet 1.50 0.60-3.73 0.39 
Surgery 1.45 0.32-6.66 0.63 
Number of visits 0.95 0.84-1.07 0.37 
Duration of follow-up visits 
(months) 
1.02 0.99-1.04 0.22 
Waiting time (months) 1.12 1.04-1.22 0.01 
OR = odds ratio; CI = confidence interval 
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Univariate logistic regression at 6 months showed that gait, language, and waiting time were 
statistically significant (p<0.05). Children with a gait that was not age-appropriate were 2.96 
(95% CI: 1.17-7.50; p-value = 0.02) times higher odds of seizure in comparison to children 
whose gait was age-appropriate. Children with language that was not age-appropriate were 
2.13 (95% CI: 1.02-4.41; p-value = 0.04) times more likely to have higher odds of seizure in 
comparison to children whose language was age-appropriate. Similarly, the analysis showed 
that waiting time per 1-month increase (OR=1.12; 95%CI, 1.04-1.22; p-value = 0.01) was 





Table 4.7: Univariate logistic regression results for prediction of seizure outcome within 12 
months (N=197) 
Variable  OR    95% CI p-value 
Sex       
   Male 1     
   Female 1.16 0.65-2.07 0.61 
Age at seizure onset 0.98 0.93-1.04 0.58 
Age at diagnosis 0.99 0.94-1.06 0.96 
Residence       
   Urban 1     
   Rural 1.52 0.85-2.74 0.16 
Gait       
   Age-appropriate                  1     
   Not age-appropriate              2.57 1.08-6.13 0.03 
Language skills       
   Age-appropriate                      1     
   Not age-appropriate            2.10 1.03-4.30 0.04 
Type of epilepsy       
   Partial 1     
  General 0.79 0.43-1.47 0.46 
Etiology       
   Unidentified      1     
   Genetic 0.67 .30-1.52 0.34 
   Structural 0.93 0.43-2.02 0.86 
Number of AEDs before first clinic 0.98 0.68-1.41 0.92 
Total number of AEDs 1.17 0.93-1.47 0.17 
EEG 1.22 0.65-2.27 0.53 
Ketogenic diet 1.55 0.63-3.86 0.34 
Surgery 2.24 0.49-10.27 0.30 
Number of visits 1.01 0.90-1.13 0.92 
Duration of follow-up visits 
(months) 
1.01 0.99-1.04 0.40 
Waiting time (months) 1.08 1.00-1.17 0.05 




In the univariate logistic regression analysis at 12 months, gait, language, and waiting time were 
statistically significant (p<0.05). Children with a gait that was not age-appropriate were 2.57 
(95% CI: 1.08-6.13; p-value = 0.03) times higher odds of seizure in comparison to children 
whose gait was age-appropriate. Children with language that was not age-appropriate were 
2.10 (95% CI: 1.03-4.30; p-value = 0.04) times higher odds of seizure in comparison to children 
whose language was age-appropriate. The analysis showed that waiting time per 1-month 
increase (OR=1.08; 95%CI, 1.00-1.17; p-value = 0.05) was associated with higher odds of 
seizure.   
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Table 4.8: Univariate logistic regression results for prediction of seizure outcome within 18 
months (N=197) 
Variable  OR    95% CI p-value 
Sex       
   Male 1     
   Female 1.04 0.63-2.05 0.68 
Age at seizure onset 0.99 0.94-1.05 0.81 
Age at diagnosis 1.01 0.95-1.07 0.81 
Residence       
   Urban 1     
   Rural 1.43 0.79-2.61 0.24 
Gait       
   Age-appropriate                  1     
   Not age-appropriate              2.60 1.10-6.19 0.03 
Language skills       
   Age-appropriate                      1     
   Not age-appropriate            2.02 0.98-4.15 0.05 
Type of epilepsy       
   Partial 1     
  General 1.30 0.70-2.43 0.41 
Etiology       
   Unidentified      1     
   Genetic 0.99 0.42-2.32 0.99 
   Structural 1.28 0.57-2.86 0.55 
Number of AEDs before first clinic 0.94 0.64-1.37 0.73 
Total number of AEDs 1.27 1.00-1.60 0.05 
EEG 1.61 0.84-3.11 0.16 
Ketogenic diet 1.53 0.61-3.83 0.37 
Surgery 1.48 0.32-6.80 0.62 
Number of visits 1.00 0.89-1.13 0.99 
Duration of Follow-up visits 
(months) 
1.02 0.99-1.05 0.18 
Waiting time (months) 1.09 1.01-1.18 0.04 




Univariate logistic regression at 18 months showed that gait, language, total number of anti-
epileptic drugs (AEDs), and waiting time were statistically significant (p<0.05). The univariate 
analysis showed that gait that was not age-appropriate were 2.60 (95% CI: 1.10-6.19; p-value 
=0.03) times higher odds of seizure. Language that was not age-appropriate had higher odds of 
seizure were 2.02 (95% CI: 0.98-4.15; p-value = 0.05) times higher odds of seizure. Per 1-AED 
increase in history, child patients had 27% (OR=1.27; 95% CI: 1.00-1.60; p-value = 0.05) higher 
odds of seizure. The waiting time per 1-month increase (OR=1.09; 95%CI, 1.01-1.18; p-value = 
0.04) was associated with higher odds of seizure. 
Table 4.9: Multivariate logistic regression results for prediction of seizure outcome within 6 
months (N=197) 
Variable  OR    95% CI p-value 
Gait       
   Age-appropriate 1     
  Not age-appropriate 3.15 1.22-8.13 0.02 
Waiting time (months) 1.13 1.04-1.23 <0.001 
OR = odds ratio; CI = confidence interval  
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In the multivariate analysis for 6 months seizure outcome, only gait and waiting time showed 
significant. Interaction between these two variables was examined but not significant. Thus, the 
final model for 6 month multivariate logistic regression showed that gait and waiting time in 
months were statistically significant factors in the analysis. A gait that was not age-appropriate 
had 3.15 (95% CI=1.22-8.13; p-value = 0.02) times higher odds of seizure when controlling for 
waiting time in months.   
Table 4.10: Multivariate logistic regression results for prediction of seizure outcome within 12 
months (N=197) 
Variable  OR    95% CI p-value 
Gait       
    Age-appropriate 1     
    Not age-appropriate 2.66 1.11-6.42 0.03 
Waiting time (months) 1.09 1.00-1.18 0.04 
OR = odds ratio; CI = confidence interval 
For the 12 month multivariate logistic regression analysis, gait and waiting time were 
statistically significant. Interaction between gait and waiting time was examined but not 
significant. A gait that was not age-appropriate associated with 2.66 (OR=2.66; 95% CI=1.11-





Table 4.11: Multivariate logistic regression results for prediction of seizure outcome within 18 
months (N=197) 
Variable  OR    95% CI p-value 
Gait       
    Age-appropriate 1     
    Not age-appropriate 3.1 1.25-7.70 0.02 
Total number of AEDs 1.36 1.10-1.75 0.02 
Waiting time (months) 1.11 1.02-1.20 0.02 
OR = odds ratio; CI = confidence interval 
18 months regression analysis showed that a gait that was not age-appropriate, total number of 
anti-epileptic drugs (AEDs) and waiting time were statistically significant. Interaction was 
examined between these three variables but found not significant. A gait that was not age-
appropriate was associated with 3.10 (OR=3.1; 95% = 1.25-7.70; p-value = 0.02) times higher 
odds of seizure, controlling for total number of AEDs and waiting time. 
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CHAPTER 5: DISCUSSION 
5.1 Summary of Findings 
The main purpose of this study was to examine and describe relationships between waiting 
time and seizure outcome among children. The present study was conducted to explore which 
seizure-related variables were most significantly associated with seizure outcome in children 
with epilepsy.  
A total of 1158 pediatric patients were included in this study held at the Royal University 
Hospital (RUH) in Saskatoon, Saskatchewan. Of those included in this sample, 378 (32.6%) child 
patients had a first seizure clinic assessment. Of the 378 child patients, 197 (52%) had epileptic 
events and were eligible for this study. 181 (48%) had non-epileptic events.   
Waiting time 
Our data showed an initial increase in waiting time as more patients attended the pediatric 
seizure clinic, however, in later years there was a decrease in waiting time as more pediatric 
neurologists staffed the clinic. The first research objective of this study was to identify if waiting 
time was associated with seizure outcome. There are very few studies that have observed 
waiting time in pediatric epilepsy. Determinants of waiting times in this study showed that 
seizure outcome associated with waiting time within 6 months, 12, months, and 18 months of 
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the seizure outcome in univariate and multivariate logistic analyses, respectively. Based on the 
descriptive analyses, child patients who had a seizure-free outcome waited an average of 3.5 
months whereas child patients who did not have a seizure-free outcome waited an average of 
4.7 months and showed to be statistically significant (p = 0.01). This finding is consistent with 
the results of other studies in which longer waiting times lead to higher odds of seizure (Berg et 
al., 2014; Luciano & Shorvon, 2007). Waiting time was also associated with residence where 
urban residents waited an average of 3.6 months and rural residents waited an average of 5.5 
months and showed statistical significance (p <.0001). This is also comparable to previous 
studies that showed the same association with residential location (Guerrini, 2006; Kenney & 
Mann, 2003; Kozyrskyi & Prasad, 2004). 
Based on the studies in this literature review and the analysis that resulted in this study, seizure 
outcome was strongly associated with having early access to the clinic. Unlike the studies in the 
literature review, the results of this study did not show a association with age at seizure onset 
or diagnosis. There was no indication that being less than a year old and being over 1 year old 
at seizure onset or diagnosis had any association with waiting time. The demographics were 
similar in terms of sex as there were more males than females diagnosed with epilepsy. This is 
similar to the demographic information of previous studies (Camfield et al., 1996; Kotsopoulos 
et al., 2002; Wirrell et al., 2011). 
Recent studies showed that four factors played a role in delaying diagnosis including reasons 
from the parents, pediatrician, neurologist, and scheduling (Berg, 2014). It was not possible to 
collect this information in our study because this would have required interviewing the parents 
and care team after diagnosis which was not effective for a retrospective study. Berg (2014) 
also used a number of standardized intelligence tests to observe the differences in language 
and development. However, our study based the assessment of development on whether or 
not the child patient was age-appropriate according to the pediatric neurologist at the time of 




The results of the multivariate analysis in our study looked at seizure outcome at 6 months, 12 
months, and 18 months to compare the variables of significance at each of these stages in the 
clinical course. The models showed that gait and waiting time significantly associated with 
seizure outcome at all three stages of epilepsy. The total number of anti-epileptic drugs (AEDs) 
was not statistically significant until 18 months of the seizure outcome. 
Our research objectives involved the identification of whether seizure outcome was associated 
with residence, gait, and language. Residence was not a predictor in any of the analyses for 
seizure outcome. Determinants of seizure outcome showed a difference of results for language 
when considered separately and when considered together. When considered separately, 
language did show up as a significant predictor in all univariate analyses but not in any 
multivariate analyses. Multivariate linear regression analysis of seizure frequency showed 
language that was not age-appropriate and general epilepsy type were significant.   
Our findings on development are similar to other studies (Barnard & Wirrell, 1999; Karrash et 
al., 2017; Weiss et al., 2016). Our study significantly associated with gait both independently 
and when considered with other variables (p-value <0.05). Barnard and Wirrell (1999) found a 
association of neurodevelopmental delay in seizure patients although the number of children 
with developmental delay based on age was likely overestimated since milder delays may not 
have been clinically obvious to families. Our study confirms two parameters that the study by 
Barnard and Wirrell (1999) could not: i) their sample size was small with 52 child patients and 
ours was 197; and ii) there was only a 3-month follow-up which may have also overestimated 
the number of children with truly persistent new developmental delay whereas ours looked at 
seizure outcome up to 18 months. A separate study that found a association between seizure 
outcome and language followed participants with childhood-onset epilepsy for over 50 years 
and participants were given standardized tests (Karrash et al., 2017). Our study did not have 
this length of follow-up time, however, language showed to be independently significant at 
each 6 months (p-value = 0.04), 12 months, (p-value = 0.04), and 18 months (p-value = 0.05).  
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Our study showed that residence did not significantly associate with seizure outcome in the 
final models but as the descriptive statistics had represented, more rural residents were not 
seizure-free (57% or 37 out of 65 patients) than urban residents who were not seizure-free 
(43% or 28 out of 65 patients).  In our study, residence was not traditionally assigned by 
population density within the province of Saskatchewan but rather was measured as being 
within the Saskatoon Health Region (urban) or beyond its borders (rural). A study in Manitoba 
found no statistically significant differences in prevalence rates of epilepsy between urban and 
rural populations of the province. However, a higher prevalence was found among children of 
all ages living in lower socioeconomic neighbourhoods in urban areas (Kozyrskyj et al., 2004). 
Our study did not collect information on parental income but did show higher prevalences of 
epilepsy amongst rural children. Another study looked at urban and rural settings for pediatric 
epilepsy and found a association with socioeconomic status (SES) (Abib et al., 2007). However, 
we did not collect this information in our study. 
Age at onset was not found to be statistically significant in the multivariate analyses of our 
study as it was in the study conducted by Huang et al. (2014). Although, the cut-off age was less 
than 12 years old for Huang’s (2014) study which may account for the difference in statistical 
significance since the cut-off age is 17 years old for our study and a considerable number of 
child patients were above the age of 12. Older age at onset predicts better prognosis in 
sporadic non-lesional temporal lobe epilepsy (TLE) (Aguglia, 2011). However, our finding is 
more in line with studies that included patients with a wider age range that did not 
demonstrate a consistent effect of age at onset on prognosis (Annegers, 1979; MacDonald, 
2000). Our finding is also similar to multivariate analyses of predictive factors in children that 
have found no independent association of age at onset with diagnosis (Berg, 2001).  
This study supports a association of the number of total anti-epileptic drugs (AEDs) consumed 
was significantly associated with seizure outcome (p-value = 0.02) which is consistent with prior 
studies (Teutonico, 2013). Through the use of multivariate statistics, Teutonico (2013) also 
indicated that consuming more than 3 AEDs along with a positive personal history, a presence 
of infantile spasms, as well as the use of stereoelectroencephalography (SEEG) resulted in a 
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poor seizure outcome for child patients with epilepsy.  A meta-analysis showed an independent 
predictor of seizure recurrence in the last year of follow-up in pediatric epilepsy was also found 
to be the number of AEDs before withdrawal (Lamberink, 2017). This is more precisely 
consistent with our results that show significance at 18 months of seizure outcome but not at 
12 months or 6 months. Previous studies documented a patient’s response to the first AED as 
the strongest predictor of long-term seizure outcome in children (Dlugos et al., 2001; Kwan & 
Brodie, 2010; Schiller & Najjar, 2008; Sillanpää, 1993). Patients with AED treatment have also 
experienced drug resistance due to genetic or environmental factors (Johnson et al., 2011). 
5.2 Study Strengths and Limitations 
5.2.1 Strengths 
There are three main strengths that this study is built upon. These involve aspects of the 
sample and data collection. 
One strength is the presence of central care as all care is provided by the same pediatric 
epilepsy clinic in Saskatchewan.  This allowed for a better sense of the clinical pathway with all 
patients going through the same administrative and clinical processes. This also allowed for 
representation of the province and allowed for the inclusion of a large population sample since 
all referrals must go through the Saskatoon Health Region (SHR), making it simpler to generalize 
to the province and therefore explore the variable of residency. 
Another notable strength is that this study was a cohort study which makes it easier to draw 
causal association. Non-observational studies such as those with a cross-sectional design do not 
allow for this advantage.  
A third strength of this study is the homogeneity of the population since this focuses on only 
children (individuals 17 years old and younger) who have had partial or generalized seizures 
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and who were seen by a pediatric neurologist at the Royal University Hospital in Saskatoon 
between the years 2012 and 2015. 
5.2.2 Limitations 
There are a number of limitations and potential biases to consider in this study involving the 
design and sample.   
One limitation is that the study design is retrospective which limits the information that can be 
collected. Additionally, not all physicians consistently collected the same information during 
appointments with their patients. A prospective study or an interview with the patients would 
have limited this bias and would have been more representative of accurate reporting. 
Retrospective case ascertainment is a potential source of bias in that identifying cases for 
inclusion in the study may depend on unfavourable outcomes, as those who experience 
recurrence will be easier to identify than those who remain seizure-free after a second or third 
seizure. It is also more likely that patients with prospective recruitment are more 
comprehensively assessed for clinical variables and history of previous seizures at the point of 
diagnosis, thereby avoiding under- or over-estimation of the seizure frequency before the 
clinical presentation.  
Another limitation of this study is that many physicians may not have referred their patient to 
the Saskatoon Health Region (SHR) pediatric neurology clinic or they may have misdiagnosed 
symptoms which would cause a bias in the sample size. The sample size was acceptable, and 
one physician would have preferred to obtain a larger number of participants. However, the 
researcher had a rather small pool from which to draw the sample given the specific inclusion 
and exclusion criterion. The SHR electronic medical records (EMR) were first in use in 2012 
amongst practicing physicians and as time passed EMRs were updated more frequently and 
were more detailed. Thus, with the small sample size, the ideal statistical procedures were not 
carried out because statistical significance may not have been ascertained. Given the sample 
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size obtained in this study, results should be interpreted with some caution as a larger sample 
size of patients diagnosed with epilepsy may have generated a contrast of results.   
Geographic location, especially proximity to an epilepsy center, may impact access to specialty 
care. Defining proximity to an epilepsy center, at the city- or township-level, is somewhat 
simplified especially for areas of Saskatchewan where regions within the province are large in 
terms of land mass. More detailed geographic data of the patient characteristics, such as 
address or postal code, would allow for better measurement of proximity. Nonetheless, this 
study provides valuable information that the impact of geography on access in seizure clinic 
services deserves further assessment.  
These limitations to the design and sample would have required more time for modification. 
Although prospective studies are strong designs for drawing causality, they are difficult to 
conduct over a short range of time. Also, the misdiagnosis of symptoms is an element of 
practice that would be a challenge to control. Though limitations are present, the conclusion 
that lengthened waiting times in pediatric epilepsy is associated with significantly increased 
odds of having seizure is still believed to be associated.  
5.3 Future Research Directions 
More research is required to support these findings and to clearly determine the mechanisms 
by which waiting times are affected. Further prospective studies and larger cohorts would be 
beneficial in providing causal explanations of the effects of waiting time in pediatric seizure 
clinics. 
The issues described in this study are not only concerning for the individual diagnosed with 
epilepsy, but they can also illustrate an economic burden for Saskatchewan. Between 2012 and 
2015, one practicing pediatric neurologist joined the clinic in each subsequent year, totalling 
four specialists by 2015. In order to minimize issue such as access, engagement, and retention 
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of patients, a considerable health care cost may provide assistance for the province. Waiting 
time highlights the need to have early intervention available for these particularly vulnerable 
populations and intervene in the progression of pediatric epilepsy. The economic burden of 
early diagnosis is likely to be substantial for Saskatchewan and may be an expense that is not 
possible to accommodate.  
Additionally, it would be of great value to reassess the variables observed here and other 
variables in a study population with a longer follow-up period. While certain variables may have 
short-term consequences, in order to identify factors which may only be evident over a longer 
period of time, a longer follow-up period or a longitudinal study would be required. The 
observation of this would allow for a more comprehensive causal relationship between the risk 
factors of seizure outcome and the clinical course experienced by patients with pediatric 
epilepsy.  
 As many risk factors as possible (where information was available) were considered for 
accessing a seizure clinic after a first seizure. Some factors need to be further explored. For 
example, availability of physicians was shown to be a factor for lengthened waiting times in the 
literature review but this information was not available for the purpose of the current study. 
During data collection, it was found that not all physicians recorded the reasons for cancelled or 
delayed appointments, whether it was due to the parent’s schedule, the child’s schedule, or the 
physician’s schedule, but this could potentially be a relevant factor to consider in future studies 
on this subject.  
The work conducted over the course of this dissertation has addressed several gaps in 
knowledge, including estimating the pooled prevalence of waiting time in persons with 
pediatric epilepsy and describing the patterns of waiting times in persons with epilepsy. Despite 
the knowledge available, the present identification and management of epilepsy continues to 
be less than ideal; by building upon the results of this work, progress can be made for the care 
of persons with epilepsy.  
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5.4 Summary  
The results of this study do not differ much from other studies; however, it provides a more 
comprehensive view of pediatric epilepsy. Identification of factors influencing pediatric seizure 
outcome is vital to effectively care for patients and to improve their quality of life. In this study, 
it was found that gait, number of anti-epileptic drugs (AEDs), and waiting time were significant 
predictors of seizure outcome. This study highlights the need for increased testing and early 
detection, dedicated resources for clinical care, and treatment access. Moreover, this study 
calls for continued research on understanding the mechanisms by which disparities exist among 
various populations with regards to epilepsy waiting times. These results could further increase 
the understanding of other health care inequalities amongst other marginalized populations.  
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CHAPTER 6: CONCLUSION 
This study attempted to address multiple disparities amongst child patients who utilize 
pediatric seizure clinic services. It also attempted to increase the knowledge and understanding 
of the Saskatoon Health Region (SHR) and amongst stakeholders regarding the disparity and its 
complex determinants among Saskatchewan‘s epileptic children and their use of pediatric 
seizure clinic services. This study will inform appropriate interventions to reduce waiting times 
at the seizure clinic in Saskatoon and beyond by disseminating the summary of the results to 
community health leaders, government, hospital administrators, as well as staff and physicians 
at the SHR. 
Physicians responsible for the care of epileptic children should be aware of the increased odds 
of seizures and visit patients appropriately. The findings from this study provide evidence that 
both demographic and clinical characteristics each serve as important determinants for access 
to the necessary pediatric epilepsy care.  
This study confirms the increasing data about patient waiting times in pediatric epilepsy onset 
and to emphasize the importance of a clinic appointment with a pediatric neurologist after a 
child experiences their first unprovoked seizure event. The findings of this study have 
potentially significant implications for a more comprehensive understanding of pediatric 
medical care services early in the diagnosis of pediatric epilepsy as this will help to prevent 
further developmental interruption. Early intervention remains a goal but with fewer resources 
available in Saskatchewan when compared to other regions of the country, it also largely 
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